In the Hot Seat: Experts Weigh In on Weight Management-Panel Discussion With Audience Question and Answer

Panel Discussion With Audience Question and Answer

Video Transcription

Video Summary

The discussion elaborates on the use and benefits of GLP-1 receptor agonists and SGLT-2 inhibitors in treating conditions like type 2 diabetes, heart failure, and obesity. The experts believe these medications can be used simultaneously, offering complementary effects. There is a noted reduction in CRP and cardiovascular mortality with these treatments. However, they caution against using these drugs for patients with specific conditions such as pancreatitis or eating disorders. The conversation also highlights that although weight loss is a factor, the drugs have additional benefits such as reducing inflammation, which contributes to positive outcomes.

Keywords

GLP-1 receptor agonists

SGLT-2 inhibitors

type 2 diabetes

cardiovascular mortality

inflammation reduction